Skip to search formSkip to main contentSkip to account menu

TGN-1412 monoclonal antibody

Known as: TGN 1412, monoclonal antibody TGN1412, TAB08 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
The failure of regulatory science to keep pace with and support the development of new biological medicines was very publically… 
Highly Cited
2011
Highly Cited
2011
Human volunteers receiving TGN1412, a humanized CD28-specific monoclonal antibody, experienced a life-threatening cytokine… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND AND PURPOSE In 2006, a life‐threatening ‘cytokine storm’, not predicted by pre‐clinical safety testing, rapidly… 
Review
2010
Review
2010
  • H. Attarwala
  • Journal of Young Pharmacists
  • 2010
  • Corpus ID: 16305905
After a drug is confirmed as safe and efficacious in preclinical studies, it is tested in healthy human volunteers for first in… 
Highly Cited
2010
Highly Cited
2007
Highly Cited
2007
The CD28-specific mAb TGN1412 rapidly caused a life-threatening “cytokine storm” in all six healthy volunteers in the Phase I… 
Highly Cited
2006
Highly Cited
2006
Six healthy young male volunteers at a contract research organization were enrolled in the first phase 1 clinical trial of… 
Highly Cited
2006
Highly Cited
2006
  • M. Goodyear
  • BMJ : British Medical Journal
  • 2006
  • Corpus ID: 32298471
This experience should foster an open culture in medical research